Indicators

Markets:

News

Latest News about REGN

Recent news which mentions REGN

< Previous 1 2 3 4 5 6 7 8 9

...

Exploring The Competitive Space: Regeneron Pharmaceuticals Versus Industry Peers In Biotechnology

July 16, 2024

Moderna, Regeneron Pharmaceuticals And 2 Other Stocks Insiders Are Selling

July 15, 2024

Stock-Split Watch: 2 Healthcare Stocks That Look Ready to Split

July 15, 2024

The Analyst Landscape: 14 Takes On Regeneron Pharmaceuticals

July 11, 2024

The 3 Most Undervalued Gene Editing Stocks to Buy in July 2024

July 09, 2024

3 No-Brainer Stocks to Buy in July

July 08, 2024

3 Pharma Stocks Already Ushering in the Next Biotech Boom

July 08, 2024

The 3 Best Biotech Stocks to Buy in July 2024

July 05, 2024

7 High Priced Stocks That Would Benefit From a Stock Split

July 04, 2024

If You Invested $1000 In This Stock 10 Years Ago, You Would Have $3,300 Today

July 04, 2024

Europe Approves Sanofi/Regeneron's Dupixent for 'Smoker's Lungs' A Month After US FDA Asks For Data

July 03, 2024

Looking Into Regeneron Pharmaceuticals's Recent Short Interest

July 02, 2024

What's Going On With Regeneron Pharmaceuticals Stock On Friday?

June 28, 2024

First Inhaled COPD Therapy In Over 2 Decades - FDA Approves Verona Pharma's First Commercial Product

June 27, 2024

3 Biotech Stocks That Could Make Your Grandchildren Rich

June 27, 2024

Looking At Regeneron Pharmaceuticals's Recent Unusual Options Activity

June 25, 2024

Regeneron Pharmaceuticals' Approach To Improve Quality Of Weight Loss Has Merit: Goldman Sachs

June 24, 2024

The Analyst Verdict: Regeneron Pharmaceuticals In The Eyes Of 13 Experts

June 24, 2024

5 Biotech Stocks With Key Catalysts This Week: Merck, Intellia, Verona, And More

June 24, 2024

Gilead Sciences Faces Wall Street Speculation About Obesity Drugs Despite Focus On Liver Treatments

June 21, 2024

Wall Street Favorites: 3 Cathie Wood Stocks With Strong Buy Ratings for June 2024

June 21, 2024

$100 Invested In This Stock 20 Years Ago Would Be Worth $10,000 Today

June 20, 2024

Regeneron's Dupixent COPD Sales To Reach $20B By 2026, Analyst Sees Larger Addressable Market

June 13, 2024

Peering Into Regeneron Pharmaceuticals's Recent Short Interest

June 11, 2024

Goldman Sachs Optimistic About Regenxbio's Gene Therapy Pipeline, Sees Over 160% Upside

June 07, 2024

Stock Split Watch: 3 Growth Stocks That Could Be Next

June 07, 2024

What's Going On With FibroGen Stock Tuesday?

June 04, 2024

3 Stocks to Watch in Active Growth ETF FDG

June 04, 2024

Competitor Analysis: Evaluating Regeneron Pharmaceuticals And Competitors In Biotechnology Industry

June 04, 2024

Navigating 14 Analyst Ratings For Regeneron Pharmaceuticals

June 04, 2024

< Previous 1 2 3 4 5 6 7 8 9

...

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.